CEO Marco Sparvieri and CFO Antonio Zamora will helm the conference call at 11:00 a.m. Mexico City time. They will be joined by Investor Relations Officer Christianne Ibañez to dissect the quarterly results and provide insights into the company’s current market standing. Participants are required to register through the company’s dedicated portal to receive access credentials for the live webcast.
Genomma Lab, which trades on the Mexican Stock Exchange under the ticker LAB B, remains a dominant player in the pharmaceutical and personal care sectors. The upcoming discussion is expected to highlight the effectiveness of the firm’s consumer-oriented marketing and its ongoing efforts to maintain a flexible, low-cost operating model across its international distribution network.
Comments (0)
No comments yet. Be the first!